Health Catalyst reported third-quarter 2026 total revenue of $56.3 million, down 26% from the prior-year period, as Adjusted EBITDA fell 94% to $779 thousand. The company posted a net income of $40.5 million, primarily driven by a $65.9 million gain on the sale of its Vitalware business in July. Revenue and profitability metrics declined due to the divestiture and headwinds from migrating clients to its Ignite platform, partially offset by cost reduction initiatives. The company reaffirmed its full-year 2026 revenue guidance of $246 million to $249 million and Adjusted EBITDA guidance of $18 million to $18.5 million. Health Catalyst operates as a healthcare intelligence company providing AI-driven technology and services to help health systems improve clinical, consumer, and cost performance.
